Pulmonary Hypertension and Systemic Diseases

Author(s): Rossella Paolini, Michela Armigliato, Sergio Zamboni

Journal Name: Current Drug Targets - Inflammation & Allergy
Continued as Inflammation & Allergy - Drug Targets

Volume 3 , Issue 4 , 2004


Secondary pulmonary hypertension (sPH) may develop as a result of few systemic diseases as endocrine diseases, HIV infection, collagen diseases, liver and hematological disorders. In this review we discuss the role of systemic diseases in inducing PH starting from a pathological classification.

Keywords: endothelial nitric oxide synthase, calcitonin, copd, endothelin-1, vasoconstrictor, growth hormone, hiv, myeloid metaplasia

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2004
Published on: 01 March, 2012
Page: [459 - 467]
Pages: 9
DOI: 10.2174/1568010042634613
Price: $65

Article Metrics

PDF: 2